This article is more than 5 years old. Information may no longer be current.

VIDEO: Spliceosomal mutations may be valuable target in myeloid leukemias

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ORLANDO, Fla. — Hetty Carraway, MD, reacts to a plenary abstract presented at the ASH Annual Meeting and Exposition that assessed the value of targeting spliceosomal mutations in myeloid leukemias. “This is very exciting for the future of our patients with myeloid leukemias, and we are eager to move forward with these clinical studies in the upcoming year,” Carraway said.